U.S. Food and Drug Administration advisors will meet Friday to consider whether it is safe and effective for Americans to receive a third “booster” dose of the Pfizer-BioNTech COVID-19 vaccine. The FDA posted the materials it intends to use in the review on Wednesday. The advisory panel will review a variety of evidence, including new…  read on >  read on >

Health officials are bracing for a viral double whammy this fall and winter. “This year, we expect influenza and COVID-19 to circulate at the same time,” said Dr. Jonathan Grein, director of hospital epidemiology at Cedars-Sinai in Los Angeles. That’s why Grein and his colleagues remind Americans that it’s time to get your seasonal flu…  read on >  read on >

America’s waistline keeps widening. On Wednesday, the U.S. Centers for Disease Control and Prevention announced that 16 states now have at least 35% of their residents who are obese, a number that’s nearly doubled since 2018. The CDC’s 2020 Adult Obesity Prevalence Maps now show that Delaware, Iowa, Ohio and Texas have joined Alabama, Arkansas,…  read on >  read on >

The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported. Between June and August, about 287,000 people who were not vaccinated were hospitalized for COVID-19 in the United States, according to data from the Kaiser Family Foundation (KFF) and the Peterson Center on Healthcare, which…  read on >  read on >

The number of U.S. infants born with syphilis is climbing at an alarming pace, reaching a high not seen since the 1990s, according to new government figures. Newborn syphilis, a potentially fatal condition, was at one time nearly eliminated in the United States. But the disease has seen a resurgence in recent years — and…  read on >  read on >

As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The Biden administration has also taken over distributing the therapeutics, to help avoid shortages…  read on >  read on >